Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
73 pending office actions • 43 art units • 69 examiners • 0 of 73 (0%) have an AI response strategy ready • 63 patents granted in the last 365 days
The Regents of the University of Colorado manage a portfolio of 72 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 68 distinct examiners and 43 distinct art units. The involvement of 43 distinct art units highlights the significant technical diversity of the university's research and patent filings.
PAZ ESTEVEZ, GUILLERMO G is the busiest examiner for this system, currently overseeing 3 pending office actions. This is a very low concentration given the total of 72 pending office actions. With 68 distinct examiners, the university must manage a vast array of individual examiner styles and requirements across its biotechnology and pharmaceutical applications.
The volume of 72 pending office actions combined with 68 distinct examiners suggests that almost every examiner is only handling a single case for the university. This decentralized environment across 43 distinct art units necessitates a highly organized approach to prosecution to ensure that legal arguments remain consistent across the entire portfolio. Practitioners should prepare for interactions with many different specialized divisions within the USPTO.
Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (7%) |
| §103 only | 23 (32%) |
| §102 only | 3 (4%) |
| §112 only | 5 (7%) |
| Multi-statute (no §101) | 37 (51%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAZ ESTEVEZ, GUILLERMO G | 3 | 21.4% | +5.0% |
| SEAMAN, D MARGARET M | 2 | 76.5% | +8.0% |
| CHAU, LISA N | 2 | 25.2% | +17.5% |
| SHIRSAT, MARCELA | 1 | 73.6% | +19.0% |
| KIM, KIHO | 1 | 85.4% | +4.5% |
| HUANG, DAVID Z | 1 | 80.3% | +13.3% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.7% | +41.4% |
| SHEN, YANXIN NMN | 1 | 90.0% | +22.5% |
| YEN, SYLING | 1 | 75.0% | +27.8% |
| GREGORY, BERNARR E | 1 | 90.5% | +6.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18972502 | FLOATING PLATFORM SYSTEM FOR MECHANICAL TESTING OF GELS AND TISSUES | HUANG, DAVID Z | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042509 | ULTRAVIOLET-ABSORPTIVE NANOPARTICLES AND MICROPARTICLES FOR INTRADERMAL USE | JANOSKO, CHASITY PAIGE | 271d overdue |
| 18127284 | COMPOSITIONS AND METHODS FOR PRODUCING AND USING ILCS TO TREAT HEALTH CONDITIONS | HAMA, JOANNE | 131d overdue |
| 17317717 | VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION | PAZ ESTEVEZ, GUILLERMO G | 128d overdue |
| 17501148 | VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION | PAZ ESTEVEZ, GUILLERMO G | 114d overdue |
| 17962656 | Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof | SEAMAN, D MARGARET M | 60d overdue |
| 18132164 | COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE | WILSON, MICHAEL C | 45d overdue |
| 16506235 | PERFORMANCE OF TECHNICAL CERAMICS | OMORI, MARY I | 31d overdue |
| 17581307 | MOTOR LEARNING AND VAGUS NERVE STIMULATION (VNS) PAIRED WITH MOTOR LEARNING TO TREAT DEMYELINATING DISEASES, CONDITIONS AND DISORDERS | LEE, ERICA SHENGKAI | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18925427 | HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS | SHEN, YANXIN NMN | 9d |
| 19143905 | SURGICAL INSTRUMENT FOR CONDITIONING LARGE DIAMETER BURR HOLES | SHIRSAT, MARCELA | — |
| 18972502 | FLOATING PLATFORM SYSTEM FOR MECHANICAL TESTING OF GELS AND TISSUES | HUANG, DAVID Z | — |
| 18863566 | IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME | OGUNBIYI, OLUWATOSIN A | — |
| 18920752 | METHODS AND DEVICES FOR A CONFIGURABLE MEDICAL INFORMATION PLATFORM | YEN, SYLING | — |
| 18285246 | CEMENT ADDITIVE FOR RETARDATION OF CEMENT HYDRATION, CEMENT MIXTURES INCLUDING SAME, AND METHODS OF FORMING AND USING SAME | CHAU, LISA N | — |
| 17436581 | LIVING STRUCTURAL MATERIAL | CHAU, LISA N | — |
| Art Unit | Apps |
|---|---|
| 3774 | 3 |
| 1682 | 3 |
| 1631 | 3 |
| 3783 | 3 |
| 3792 | 2 |
| 1797 | 2 |
| 1617 | 2 |
| 1785 | 2 |
| 1767 | 2 |
| 3775 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19143905 | SURGICAL INSTRUMENT FOR CONDITIONING LARGE DIAMETER BURR HOLES | SHIRSAT, MARCELA | 3775 | §102§103 | Final Rejection | — | Pending | Jun 27, 2025 |
| 19057550 | Scanner Utilizing Beam Computed Tomography And Antiscatter Grid | KIM, KIHO | — | §102§103 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 18972502 | FLOATING PLATFORM SYSTEM FOR MECHANICAL TESTING OF GELS AND TISSUES | HUANG, DAVID Z | — | §112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18864247 | ANTIBIOTIC COMPOSITION AND METHODS OF USE THEREOF | SEAMAN, D MARGARET M | 1629 | §103 | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18863566 | IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME | OGUNBIYI, OLUWATOSIN A | — | §102§103§112 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18925427 | HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS | SHEN, YANXIN NMN | 1663 | §103§112 | Non-Final OA | 9d | Pending | Oct 24, 2024 |
| 18920752 | METHODS AND DEVICES FOR A CONFIGURABLE MEDICAL INFORMATION PLATFORM | YEN, SYLING | 3687 | §103 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18885581 | Inter-Frequency Signal Aiding For Tracking Satellite Navigation Signals | GREGORY, BERNARR E | 3648 | §101§103§112 | Non-Final OA | — | Pending | Sep 14, 2024 |
| 18817015 | VENTRICULAR ASSIST ASSEMBLY, SYSTEM, AND METHOD | CIRULNICK, EMILY NICOLE | 3792 | §102§103§112Other | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18839131 | SMALL MOLECULES TARGETTING EIF3E TO INHIBIT TUMOR GROWTH PROGRESSION, AND METASTASIS | AULAKH, CHARANJIT | — | §102§112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18837842 | PLASMON-ENHANCED FLUORESCENCE BIOCHEMICAL SENSORS | EOM, ROBERT J | 1797 | §103 | Non-Final OA | 20d | Pending | Aug 12, 2024 |
| 18800335 | SYNTHESIS OF BACKBONE MODIFIED MORPHOLINO OLIGONUCLEOTIDES AND CHIMERAS USING PHOSPHORAMIDITE CHEMISTRY | RILEY, JEZIA | — | §102§103§112Other | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18784462 | DEVICES FOR IMPLANTATION OF CELLULAR TRANSPLANTS AND METHODS OF USING THE SAME | MULLINS, JESSICA LYNN | 3792 | §102§103§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18765795 | INTACT PILL DELIVERY SYSTEM | THOMAN, EVELYN ANNE | — | §103§112 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18750876 | RHEOLOGICALLY MODIFIED LIQUID METAL DEVICES AND RELATED SYSTEMS AND METHODS | SMOOT, MORIAH SIMONE MCMIL | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18746960 | ELECTRON-ENHANCED METAL OXIDE ATOMIC LAYER DEPOSITION | MATTABONI, TIMOTHY JAMES | — | §103 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18648678 | METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10 | NOBLE, MARCIA STEPHENS | — | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18627309 | CELLULAR TRANSPLANT CARRIER DEVICES AND METHODS OF USING THE SAME | GRAY, PHILLIP A | — | §102§103§112 | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18627155 | COMPOSITIONS AND METHODS FOR REDUCING ADVERSE EFFECTS OF STORAGE, TRANSPORT AND ADMINISTRATION OF ANTIGEN-CONTAINING FORMULATIONS | ZHANG SPIERING, DONGXIU | 1616 | §103§112 | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18622525 | COMPOSITIONS AND METHODS FOR REDUCED TOXICITY IN TRANSPLANTATION USING JANUS KINASE (JAK) INHIBITORS | PYLA, EVELYN Y | — | §102§103§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18697411 | DIAGNOSING MULTIPLE SCLEROSIS (MS) | COLE, HOUSTON DAVID | — | §101§102§103§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18585791 | Crystalline Sp-Sp2 Hybridized Carbon Allotropes through Dynamic Covalent Synthesis | KUMAR, SRILAKSHMI K | — | §102§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18686115 | IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS | EZELUOMBA, MIRIAM NCHEKWUBECHU | 1776 | §103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18685045 | CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS | LOCKARD, JON MCCLELLAND | — | §112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18429212 | OPHTHALMIC IMPLANT SYSTEM FOR DRUG DELIVERY | SHARMA, YASHITA | 3774 | §102§103 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18293258 | Dynamic Assessment Of Airway Deformation | AZIMA, SHAGHAYEGH | 2671 | §103 | Non-Final OA | 23d | Pending | Jan 29, 2024 |
| 18412205 | REVERSE THERMAL GELS AND THEIR USE AS VASCULAR EMBOLIC REPAIR AGENTS | PIPIC, ALMA | 1617 | §103§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18396386 | SURFACE BRACHYTHERAPY DEVICE, APPLICATOR, AND METHODS THEREFOR | CASLER, BRIAN L | — | §102§103 | Non-Final OA | — | Pending | Dec 26, 2023 |
| 18573907 | PEROXIDE-ENHANCED GERMICIDAL IRRADIATION FOR THE TREATMENT OF AIRBORNE AND SURFACE-ASSOCIATED CONTAMINANTS | CHEN, CHANGRU | 1796 | §103 | Final Rejection | 12d | Pending | Dec 22, 2023 |
| 18562035 | COMPOSITIONS AND METHODS FOR PRODUCING AND USING CELL-BASED IMMUNOTHERAPIES TO TARGET TUMORS | HOLTZMAN, KATHERINE ANN | — | §102§103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18506637 | COMPOSITIONS AND METHODS OF USE FOR MUTATED HOTAIR IN THE TREATMENT OF CANCERS | KONOPKA, CATHERINE ANNE | 1635 | §112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18481830 | SULCUS IMPLANTS AND METHODS OF USING THE SAME | LOPEZ, LESLIE ANN | 3774 | §102 | Final Rejection | 83d | Pending | Oct 05, 2023 |
| 18375953 | CLUTCH SYSTEM FOR A POWERED PROSTHETIC DEVICE | CROWE, RAEGAN NADIA | 3774 | §102 | Non-Final OA | — | Pending | Oct 02, 2023 |
| 18285246 | CEMENT ADDITIVE FOR RETARDATION OF CEMENT HYDRATION, CEMENT MIXTURES INCLUDING SAME, AND METHODS OF FORMING AND USING SAME | CHAU, LISA N | 1785 | §102§103§112 | Non-Final OA | — | Pending | Sep 30, 2023 |
| 18279769 | METHODS AND DEVICES FOR NUCLEIC ACID DETECTION | JONES, CHRISTINE MICHELLE | 1682 | §103 | Final Rejection | 13d | Pending | Sep 01, 2023 |
| 18237705 | COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF PLATINUM-BASED CHEMOTHERAPEUTIC RESISTANT TUMORS | LEE, WILLIAM Y | 1623 | §102§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18274858 | ELECTROLYTE FOR DURABLE DYNAMIC GLASS BASED ON REVERSIBLE METAL ELECTRODEPOSITION | KING, GEORGE G | 2872 | §103§112 | Final Rejection | 41d | Pending | Jul 28, 2023 |
| 18359793 | Novel Peptide Carrier Compositions | BANERJEE, KOYELI | 1658 | §103 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18271727 | METHODS AND COMPOSITIONS FOR MOLECULAR TRACKING IN INDIVIDUAL CELLS IN VIVO | YOUNG, BRIAN ELLIS | 1682 | §102§103§112 | Non-Final OA | — | Pending | Jul 11, 2023 |
| 18318926 | HYBRID POLYMER/CRYSTAL PHOTOMECHANICAL MATERIALS | ANGEBRANNDT, MARTIN J | 1737 | §103§112 | Non-Final OA | 56d | Pending | May 17, 2023 |
| 18133784 | COMPOSITIONS AND METHODS FOR LOWERING INTRACRANIAL PRESSURE | FAY, ZOHREH ALEMZADEH | 1617 | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2023 |
| 18298967 | PULSED ELECTRODEPOSITION FOR REVERSIBLE METAL ELECTRODEPOSITION TO CONTROL METAL FILM MORPHOLOGY AND OPTICAL PROPERTIES | DOWNES, NATHANAEL JASON | 1794 | §103§112 | Non-Final OA | — | Pending | Apr 11, 2023 |
| 18132164 | COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE | WILSON, MICHAEL C | 1638 | §102§112Other | Final Rejection | 45d overdue | Pending | Apr 07, 2023 |
| 18127284 | COMPOSITIONS AND METHODS FOR PRODUCING AND USING ILCS TO TREAT HEALTH CONDITIONS | HAMA, JOANNE | 1647 | §101§103§112 | Non-Final OA | 131d overdue | Pending | Mar 28, 2023 |
| 18245749 | SIGNATURES IN CELL-FREE DNA TO DETECT DISEASE, TRACK TREATMENT RESPONSE, AND INFORM TREATMENT DECISIONS | BUCHANAN, BAILEY CHEYENNE | 1682 | §102§103§112 | Final Rejection | — | Pending | Mar 17, 2023 |
| 18175418 | Method for Determining Medication Adherence and Taggants Therefo | ALABI, OYELEYE A | 1797 | §103 | Final Rejection | 78d overdue | Pending | Feb 27, 2023 |
| 18175225 | METHOD OF TREATMENT OF PATIENTS HAVING REDUCED SENSITIVITY TO A BCL-2 INHIBITOR | KAUFMAN, CLAIRE M | 1674 | §102§103§112Other | Non-Final OA | — | Pending | Feb 27, 2023 |
| 18042509 | ULTRAVIOLET-ABSORPTIVE NANOPARTICLES AND MICROPARTICLES FOR INTRADERMAL USE | JANOSKO, CHASITY PAIGE | 1613 | §103§112 | Final Rejection | 271d overdue | Pending | Feb 22, 2023 |
| 18096668 | ELECTRON-ENHANCED ATOMIC LAYER DEPOSITION (EE-ALD) METHODS AND DEVICES PREPARED BY SAME | MCCLURE, CHRISTINA D | 1718 | §103 | Non-Final OA | 56d | Pending | Jan 13, 2023 |
| 18084105 | METHOD FOR REDUCING OFF-TARGET UPTAKE OR ACCUMULATION OF AGENTS | HUMPHRIES, NICHOLAS ADAM | 1631 | §103 | Non-Final OA | — | Pending | Dec 19, 2022 |
| 18011106 | METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS | ROSWELL, JESSICA MARIE | 1767 | §103 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 17997575 | MULTISPECIFIC ANTI-FLT3 CHIMERIC ANTIGEN RECEPTORS | ABUZEINEH, HANAN ISAM | 1633 | §103 | Final Rejection | — | Pending | Oct 31, 2022 |
| 17962656 | Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof | SEAMAN, D MARGARET M | 1625 | §102§112 | Final Rejection | 60d overdue | Pending | Oct 10, 2022 |
| 17953221 | SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER | AGUIRRE, AMANDA L | 1626 | §102 | Final Rejection | — | Pending | Sep 26, 2022 |
| 17802842 | POST-OPERATIVE SURGICAL SITE WOUND TREATMENT AND METHOD FOR DEVICE REMOVAL | CHATRATHI, ARJUNA P | 3781 | §103 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17766387 | Micron Sized Droplets With Solid Endoskeleton or Exoskeleton Which Tunes The Thermal Stability of The Liquid Droplets | STANLEY, JANE L | 1767 | §102§112 | Non-Final OA | — | Pending | Apr 04, 2022 |
| 17704746 | METHODS AND COMPOSITIONS COMPRISING A CD93/IGFBP7 BLOCKING AGENT FOR TREATING CANCER | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §112 | Final Rejection | — | Pending | Mar 25, 2022 |
| 17635320 | ACID-RESISTANT INORGANIC COMPOSITE MATERIAL AND METHOD OF FORMING SAME | KUVAYSKAYA, ANASTASIA ALEKSEYEVNA | 1731 | §103 | Non-Final OA | — | Pending | Feb 14, 2022 |
| 17634676 | POLYURETHANE-REINFORCED HYDROGEL CARDIAC PATCH | MILLER, SERENITY A | 3771 | §103 | Non-Final OA | — | Pending | Feb 11, 2022 |
| 17581307 | MOTOR LEARNING AND VAGUS NERVE STIMULATION (VNS) PAIRED WITH MOTOR LEARNING TO TREAT DEMYELINATING DISEASES, CONDITIONS AND DISORDERS | LEE, ERICA SHENGKAI | 3796 | §103§112 | Non-Final OA | 4d overdue | Pending | Jan 21, 2022 |
| 17511228 | GENERATION OF FUNCTIONAL AND PATIENT-SPECIFIC THYMIC TISSUE FROM INDUCED PLURIPOTENT STEM CELLS | SCHULTZ, JAMES | 1631 | §102§112 | Final Rejection | 4d overdue | Pending | Oct 26, 2021 |
| 17501148 | VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION | PAZ ESTEVEZ, GUILLERMO G | 3783 | §103 | Non-Final OA | 114d overdue | Pending | Oct 14, 2021 |
| 17436581 | LIVING STRUCTURAL MATERIAL | CHAU, LISA N | 1785 | §103 | Non-Final OA | — | Pending | Sep 03, 2021 |
| 17317717 | VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION | PAZ ESTEVEZ, GUILLERMO G | 3783 | §103 | Non-Final OA | 128d overdue | Pending | May 11, 2021 |
| 17317676 | VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION | PAZ ESTEVEZ, GUILLERMO G | 3783 | §103 | Non-Final OA | — | Pending | May 11, 2021 |
| 17266502 | PARN AS A BIOMARKER AND THERAPEUTIC TARGET | TRAN, CHRISTINA L | 1637 | §101§103§112Other | Non-Final OA | — | Pending | Feb 05, 2021 |
| 16960445 | 3D in vitro Models of Lung Tissue | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | 91d overdue | Pending | Jul 07, 2020 |
| 16506235 | PERFORMANCE OF TECHNICAL CERAMICS | OMORI, MARY I | 1784 | §103§112 | Non-Final OA | 31d overdue | Pending | Jul 09, 2019 |
| 18777718 | NOVEL OVERLAYER FILMS AND METHODS FOR ETCHING SILICON-CONTAINING MATERIALS USING A LOW TEMPERATURE DRY CHEMICAL ETCH PROCESS | VO, TUYEN KIM | 2876 | §103 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18190623 | AUTOMATED PLATFORM TO TREAT TRAUMA-INDUCED COAGULOPATHY WITH PERSONALIZED COAGULATION FACTOR CONCENTRATIONS | ANDERSON-FEARS, KEENAN NEIL | — | §101§102 | Non-Final OA | — | Pending | Mar 27, 2023 |
| 17922522 | METHODS AND SYSTEMS FOR ENHANCING DELIVERY OF THERAPEUTIC AGENTS TO BIOFILMS USING LOW BOILING POINT PHASE CHANGE CONTRAST AGENTS | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Final Rejection | — | Pending | Oct 31, 2022 |
| 18050192 | Compositions and Methods for Treating Cancer with TSLPR-CD19 or TSLPR-CD22 Immunotherapy | MARVICH, MARIA | — | §112 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17244333 | VIRAL TESTING IN SALIVA | GILL, RACHEL B | 1671 | §103Other | Non-Final OA | — | Pending | Apr 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial